Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Plans of Merger with FinLab AG
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Plans of Merger with FinLab AG
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Plans of Merger with FinLab AG
EQS-News: UET United Electronic Technology AG starts with 40% revenue growth into fiscal year 2023
EQS-News: UET United Electronic Technology AG starts with 40% revenue growth into fiscal year 2023
EQS-News: UET United Electronic Technology AG starts with 40% revenue growth into fiscal year 2023
EQS-News: Dermapharm Holding SE:  outstanding start  to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group Acquires Stryze Group and Secures Further Equity Investment to Strengthen its Position as Leading E-Commerce Aggregator
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group Acquires Stryze Group and Secures Further Equity Investment to Strengthen its Position as Leading E-Commerce Aggregator
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group Acquires Stryze Group and Secures Further Equity Investment to Strengthen its Position as Leading E-Commerce Aggregator
EQS-News: UET United Electronic Technology AG publishes preliminary figures for fiscal year 2022
EQS-News: UET United Electronic Technology AG publishes preliminary figures for fiscal year 2022
EQS-News: UET United Electronic Technology AG publishes preliminary figures for fiscal year 2022
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA successfully completes capital increase.
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA successfully completes capital increase.
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA successfully completes capital increase.
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: UET United Electronic Technology AG: UET Group improves resilience of telecommunication networks in the event of blackouts
EQS-News: UET United Electronic Technology AG: UET Group improves resilience of telecommunication networks in the event of blackouts
EQS-News: UET United Electronic Technology AG: UET Group improves resilience of telecommunication networks in the event of blackouts
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA resolves cash capital increase with subscription rights of up to 1,818,181 new shares (~16.2 percent of share capital)
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA resolves cash capital increase with subscription rights of up to 1,818,181 new shares (~16.2 percent of share capital)
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA resolves cash capital increase with subscription rights of up to 1,818,181 new shares (~16.2 percent of share capital)
EQS-News: United Electronic Technology (UET) AG publishes selected, preliminary financial figures for fiscal year 2022
EQS-News: United Electronic Technology (UET) AG publishes selected, preliminary financial figures for fiscal year 2022
EQS-News: United Electronic Technology (UET) AG publishes selected, preliminary financial figures for fiscal year 2022
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C
EQS-News: UET United Electronic Technology AG: UET Group creates with quantum cryptography secure communications in telecommunications networks
EQS-News: UET United Electronic Technology AG: UET Group creates with quantum cryptography secure communications in telecommunications networks
EQS-News: UET United Electronic Technology AG: UET Group creates with quantum cryptography secure communications in telecommunications networks
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned
EQS-News: UET United Electronic Technology AG with revenues growth amid challenging market conditions in first half of fiscal year 2022
EQS-News: UET United Electronic Technology AG with revenues growth amid challenging market conditions in first half of fiscal year 2022
EQS-News: UET United Electronic Technology AG with revenues growth amid challenging market conditions in first half of fiscal year 2022
EQS-News:  UET United Electronic Technology AG plans expansion of the current financing round for investments
EQS-News: UET United Electronic Technology AG plans expansion of the current financing round for investments
EQS-News: UET United Electronic Technology AG plans expansion of the current financing round for investments
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad has signed the UN-supported Principles for Responsible Investments (PRI)
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad has signed the UN-supported Principles for Responsible Investments (PRI)
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad has signed the UN-supported Principles for Responsible Investments (PRI)
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm Holding SE: Successful first half of 2022 in challenging market environment
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
DGAP-Adhoc: Dermapharm Holding SE: binding offer to acquire Arkopharma Group
Edison Investment Research Limited: Heliad Equity Partners (HEP): Initiation - A high-tech growth investor from Germany
Edison Investment Research Limited: Heliad Equity Partners (HEP): Initiation - A high-tech growth investor from Germany
Edison Investment Research Limited: Heliad Equity Partners (HEP): Initiation - A high-tech growth investor from Germany